Triple combination therapy of favipiravir plus two monoclonal antibodies eradicates influenza virus from nude mice
Clicks: 270
ID: 265988
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
270 views
40 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #47 of 69 articles by views in Communications biology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Kiso et al. develop combination therapy of the viral polymerase inhibitor favipiravir and monoclonal antibodies against the receptor-binding site and stem of viral hemagglutinin. They show that triple, but not double, combination therapy is able to eradicate the influenza virus from nude mice. Their work provides insights on therapeutic options for immunocompromised patients.
| Reference Key |
kiso2020communicationstriple
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Maki Kiso;Seiya Yamayoshi;Yoshihiro Kawaoka;Maki Kiso;Seiya Yamayoshi;Yoshihiro Kawaoka; |
| Journal | Communications biology |
| Year | 2020 |
| DOI |
doi:10.1038/s42003-020-0952-y
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.